Epigral Limited has announced comprehensive arrangements for the disclosure of its fourth quarter and financial year 2026 results. The company will conduct a board meeting on Saturday, May 2, 2026, followed by a conference call with investors and analysts to discuss the financial performance.

Board Meeting Details

The board of directors will convene at the company's registered office to consider and approve crucial financial matters. The meeting agenda encompasses multiple key decisions for stakeholders.

Conference Call Announcement

Following the board meeting, Epigral Limited will host a conference call on Saturday, May 2, 2026, at 4:30 PM IST to discuss the Q4FY26 results. The call is organized in collaboration with Emkay Global Financial Services Ltd and will feature senior management participation.

Management Participation

The conference call will include key executives from Epigral Limited:

Access Information

Investors can participate through multiple channels, with pre-registration available for express access. The company has provided comprehensive dial-in facilities including universal access numbers and international toll-free options across various countries including the United States, United Kingdom, Germany, Australia, and several Asian markets.

Both announcements have been communicated to the National Stock Exchange of India Limited and BSE Limited in compliance with SEBI regulations. The communications were signed by Gaurang Trivedi, Company Secretary & Compliance Officer of Epigral Limited.

Epigral Limited has issued a postal ballot notice seeking shareholder approval for the reappointment of three Non-Executive Independent Directors for their second consecutive terms. The board of directors approved these appointments through a circular resolution dated April 16, 2026, following recommendations from the Nomination and Remuneration Committee.

E-Voting Schedule and Process

The company has engaged Central Depository Services (India) Limited (CDSL) to provide e-voting facility to its members. The postal ballot notice has been sent electronically to members whose email addresses are registered with the company or their Depository Participants.

Director Reappointment Details

All three directors are being reappointed for their second term of five consecutive years, effective from May 20, 2026, to May 19, 2031. The appointments require shareholder approval through special resolutions.

Director Profiles and Expertise

Mr. Sanjay Asher (DIN: 00008221) brings extensive legal expertise as a Senior Partner with Crawford Bayley and Co., India's oldest law firm established in 1830. He specializes in mergers and acquisitions, cross-border M&A, joint ventures, private equity, and capital markets. He holds Bachelor's degrees in Commerce and Law from the University of Bombay, is a qualified Chartered Accountant, and was admitted as a Solicitor in 1993. He received ₹7.75 lakh as sitting fees during FY 2025-26.

Mr. Kanubhai Patel (DIN: 00008395) contributes over three decades of experience in finance, marketing, and commercial matters. His career includes serving as Executive Director since 1995, Joint Managing Director from 2002, and Chairman and Managing Director from 2013 at Voltamp Transformers Limited. He holds a Bachelor's degree in Commerce and is a Fellow Member of both the Institute of Chartered Accountants of India and the Institute of Company Secretaries of India. He received ₹8.50 lakh as sitting fees during FY 2025-26.

Mr. Raju Swamy (DIN: 03032679) brings over 40 years of experience in family business consulting through PROMAG Consultancy Services. His expertise covers structure, strategy, governance, trust, ownership, professionalization, continuity, succession, and growth aspects of family businesses. He holds an MBA from IIM Calcutta's first batch and received ₹4.75 lakh as sitting fees during FY 2025-26. His reappointment also requires special approval as he has attained 75 years of age.

Regulatory Compliance and Process

The reappointments comply with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. All three directors have confirmed their independence and submitted necessary declarations regarding their eligibility and compliance with regulatory requirements.